Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Four New York-based agencies are vying for creative and media duties on a new cholesterol drug from Merck & Co. and Schering-Plough, sources said.
The agencies are DDB, Grey Worldwide, Young & Rubicam and Robert A. Becker/Euro RSCG, according to sources. Becker specializes in pharmaceutical and health-care advertising.
Each shop has been asked to develop positioning and creative ideas. In addition, the client asked the participants to draw up a budget for the new, as yet-unnamed brand, sources said.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in